Merck & Co. 21. Mai 2026 ASCO: Merck, Kelun's sac-TMT ADC combo beats Keytruda by 65% on progression in first-line lung cancer - Fierce Pharma
Merck & Co. 20. Mai 2026 EXEL Collaborates With MRK for Late-Stage Colorectal Cancer Study - TradingView
Merck & Co. 19. Mai 2026 Merck inks Keytruda supply pact to support Exelixis cancer trial - Fierce Biotech
Merck & Co. 18. Mai 2026 Results Reinforce Merck/Kelun’s Sac-TMT As Major TROP2 Player - Citeline News & Insights
Merck & Co. 18. Mai 2026 Merck ADC, licensed from China, hits mark in first big global trial - BioPharma Dive
Merck & Co. 18. Mai 2026 Merck & Co.'s first pivotal study of sac-TMT comes up trumps - FirstWord Pharma
Merck & Co. 18. Mai 2026 Microbiotica Announces Positive Results from its Phase 1b Trial (MELODY-1) of MB097, a Precision Microbiome Co-Therapy in Advanced Melanoma - The Manila Times
Merck & Co. 16. Mai 2026 Merck & Co., Inc. stock (US58933Y1055): Keytruda momentum and fresh earnings keep big pharma in focu - AD HOC NEWS
Merck & Co. 15. Mai 2026 Merck & Co., Inc. stock (US58933Y1055): pharma giant doubles down on M&A as investors eye post-Keytr - AD HOC NEWS
Merck & Co. 14. Mai 2026 AstraZeneca scores with Imfinzi in another bladder cancer trial, rivaling Merck's Keytruda - Fierce Pharma
Merck & Co. 14. Mai 2026 Merck & Co., Inc. stock (US58933Y1055): Latest developments and business overview - AD HOC NEWS
Merck & Co. 13. Mai 2026 Cortisone Shots Market 2026 | Merck & Co, Pfizer, Bristol-Myers Squibb, Novartis, Pharmascience etc. - openPR.com
Merck & Co. 12. Mai 2026 Merck & Co. stock (US58933Y1055): Oncology portfolio advances at ASCO 2026 - AD HOC NEWS
Merck & Co. 12. Mai 2026 Achieve Life Sciences Strengthens Board and Commercial Leadership with Three Senior Appointments from Team Previously at Verona Pharma - The Manila Times
Merck & Co. 12. Mai 2026 Erasca partners with Merck on best-in-class pan-RAS molecular glue - The Pharma Letter
Merck & Co. 11. Mai 2026 Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
Merck & Co. 11. Mai 2026 Merck makes a new move in Astra battle | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
Merck & Co. 11. Mai 2026 Amid M&A buzz, Inhibrx's OX40-Keytruda combo shows promise in early look at midphase data - Fierce Biotech